Comparison of deferoxamine and methylprednisolone: Protective effect of pharmacological agents on lipid peroxidation in spinal cord injury in rats

Spine

Volumn 38, Issue 26, 2013, Pages

  Dinc, Cem ^a   Iplikcioglu, Ahmet Celal ^b   Atabey, Cem ^c   Eroglu, Ahmet ^c   Topuz, Kivanc ^c   Ipcioglu, Osman ^c   Demirel, Dilaver ^c  

^a Department of Neurosurgery   (Turkey)

^b Bayindir Icerenkoy Hospital   (Turkey)

^c GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

deferoxamine; lipid peroxidation; methylprednisolone; spinal cord injury

Indexed keywords

CATALASE; DEFEROXAMINE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; METHYLPREDNISOLONE; PREDNOL L; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EDEMA; HISTOPATHOLOGY; LAMINECTOMY; LIPID PEROXIDATION; LYMPHOCYTE; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NONHUMAN; PARAPLEGIA; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SPINAL CORD; SPINAL CORD INJURY; WHITE MATTER;

ANIMALS; CATALASE; COMBINED MODALITY THERAPY; DEFEROXAMINE; GLUTATHIONE PEROXIDASE; LAMINECTOMY; LIPID PEROXIDATION; LOGISTIC MODELS; MALE; MALONDIALDEHYDE; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SIDEROPHORES; SPINAL CORD; SPINAL CORD INJURIES; SUPEROXIDE DISMUTASE;

EID: 84891559461     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0000000000000055     Document Type: Article

References (49)

1. Amar AP, Levy ML. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 1999; 44: 1027-39.
2. Reiter RJ, Poeggeler B, Tan DX. Antioxidant capacity of melato-nin: a novel action not requiring receptor. Neuroendocrinol Lett 2005; 15: 103-116.
3. Vanderveldt GM, Regan RF. The neurotoxic effect of sickle cell hemoglobin. Free Radic Res 2004; 38: 431-7.
4. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991; 75: 15-26.
5. Yu J, Guo Y, Sun M, et al. Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons. Brain Res 2009; 1257: 102-7.
6. Labombarda F, González S, Lima A, et al. Progesterone attenuates astro-and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury. Exp Neurol 2011; 231: 135-46.
7. Lankhorst AJ, Duis SE, ter Laak MP, et al. Functional recovery after central infusion of alpha-melanocyte-stimulating hormone in rats with spinal cord contusion injury. J Neurotrauma 1999; 16: 323-31.
8. Vitellaro-Zuccarello L, Mazzetti S, Madaschi L, et al. Chronic erythropoietin-mediated effects on the expression of astrocyte markers in a rat model of contusive spinal cord injury. Neuroscience 2008; 151: 452-66.
9. Anderson DK, Hall ED. Pathophysiology of spinal cord trauma. Ann Emerg Med 1993; 22: 987-92.
10. Anderson DK, Means ED, Waters TR, et al. Spinal cord energy metabolism following compression trauma to the feline spinal cord. J Neurosurg 1980; 53: 375-80.
11. Braughler JM, Hall ED. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med 1989; 6: 289-301.
12. Ulakoglu EZ, Saygi A, Gümüs, tas, MK, et al. Alterations in super-oxide dismutase activities, lipid peroxidation and glutathione levels in thinner inhaled rat lungs: relationship between histopathological properties. Pharmacol Res 1998; 38: 209-14.
13. Halliwell B, Gutteridge JM. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986; 246: 501-14.
14. Schültke E, Kendall E, Kamencic H, et al. Quercetin promotes functional recovery following acute spinal cord injury. J Neurotrauma 2003; 20: 583-91.
15. Gutteridge JM, Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of "free" iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J 1981; 199: 263-5.
16. Braughler JM, Hall ED. Involvement of lipid peroxidation in CNS injury. J Neurotrauma 1992; 9 (suppl 1): S1-7.
17. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 2nd ed. Oxford: Oxford University Press; 1989.
18. Walters BC, Hadley MN, Hurlbert RJ, et al. Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update. Neurosurgery 2013; 60: 82-91.
19. Christie SD, Comeau B, Myers T, et al. Duration of lipid peroxida-tion after acute spinal cord injury in rats and the effect of methyl-prednisolone. Neurosurg Focus 2008; 25: E5.
20. Bracken MB, Shepard MJ, Collins W F, Jr, et al. Methylpredniso-lone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg. 1992; 76: 23-31.
21. Bracken MB, Shepard MJ, Collins WF, et al. Randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322: 1405-11.
22. Bracken MB, Shepard MJ, Hellenbrand KG, et al. Methylpred-nisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg 1985; 63: 704-13.
23. Braughler JM, Hall ED. Current application of "high-dose" steroid therapy for CNS injury. A pharmacological perspective. J Neurosurg 1985; 62: 806-10.
24. Rivlin AS, Tator CH. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 1978; 10: 38-43.
25. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
26. Hall ED, Braughler JM. Free radicals in CNS injury. Res Publ Assoc Res Nerv Ment Dis 1993; 71: 81-105.
27. Jamme I, Petit E, Divoux D, et al. Modulation of mouse cerebral Na +, K(+)-ATPase activity by oxygen free radicals. Neuroreport 1995;7: 333-7.
28. Schmidley JW. Free radicals in central nervous system ischemia. Stroke 1990; 21: 1086-90.
29. Konat GW, Wiggins RC. Effect of reactive oxygen species on myelin membrane proteins. J Neurochem 1985; 45: 1113-8.
30. Fujimoto T, Nakamura T, Ikeda T, et al. Effects of EPC-K1 on lipid peroxidation in experimental spinal cord injury. Spine 2000; 25: 24-9.
31. Kalayci M, Coskun O, Cagavi F, et al. Neuroprotective effects of ebselen on experimental spinal cord injury in rats. Neurochem Res 2005; 30: 403-10.
32. Topsakal C, Erol FS, Ozveren MF, et al. Effects of methylpred-nisolone and dextromethorphan on lipid peroxidation in an experimental model of spinal cord injury. Neurosurg Rev 2002; 25: 258-66.
33. Black P, Markowitz RS, Keller S, et al. Naloxone and experimental spinal cord injury: Part 2. Megadose treatment in a dynamic load injury model. Neurosurgery 1986; 19: 909-13.
34. Fercakova A, Halat G, Marsala M, et al. Graded postischemic reoxygenation reduces lipid peroxidation and reperfusion injury in the rabbit spinal cord. Brain Res 1992; 593: 159-67.
35. Hall ED. Lipid antioxidants in acute central nervous system injury. Ann Emerg Med 1993; 22: 1022-7.
36. Hall ED. The neuroprotective pharmacology of methylpredniso-lone. J Neurosurg 1992; 76: 13-22.
37. Saunders RD, Dugan LL, Demediuk P, et al. Effects of methylpred-nisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J Neurochem 1987; 49: 24-31.
38. Palmer C, Roberts RL, Bero C. Deferoxamine post-treatment reduces ischemic brain injury in neonatal rats. Stroke 1994; 25: 1039-45.
39. Song W, Su H, Song S, et al. Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J Cell Physiol 2006; 206: 655-63.
40. Yao SY, Soutto M, Sriram S. Preconditioning with cobalt chloride or desferrioxamine protects oligodendrocyte cell line (MO3.13) from tumor necrosis factor-alpha-mediated cell death. J Neurosci Res 2008; 86: 2403-13.
41. Aguiar AS, Jr, Tuon T, Soares FS, et al. The effect of n-acetylcyste-ine and deferoxamine on exercise-induced oxidative damage in stri-atum and hippocampus of mice. Neurochem Res 2008; 33: 729-36.
42. Means ED, Anderson DK, Waters TR, et al. Effect of methylprednis-olone in compression trauma to the feline spinal cord. J Neurosurg 1981; 55: 200-8.
43. Keberle H. The biochemistry of desferrioxamine and its relation to iron metabolism. Ann N Y Acad Sci 1964; 119: 758-68.
44. Cayli SR, Ates O, Karadag N, et al. Neuroprotective effect of etomi-date on functional recovery in experimental spinal cord injury. Int J Dev Neurosci 2006; 24: 233-9.
45. Benzel EC, Lancon JA, Thomas MM, et al. A new rat spinal cord injury model: a ventral compression technique. J Spinal Disord 1990; 3: 334-8.
46. Liu J, Tang T, Yang H. Protective effect of deferoxamine on experimental spinal cord injury in rat. Injury 2011; 42: 742-5.
47. Paterniti I, Mazzon E, Emanuela E, et al. Modulation of inflamma-tory response after spinal cord trauma with deferoxamine, an iron chelator. Free Radic Res 2010; 44: 694-709.
48. Serarslan Y, Yönden Z, Ozgiray E, et al. Protective effects of tadalafil on experimental spinal cord injury in rats. J Clin Neurosci 2010; 17: 349-52.
49. Topuz K, Colak A, Cemil B, et al. Combined hyperbaric oxygen and hypothermia treatment on oxidative stress parameters after spinal cord injury: an experimental study. Arch Med Res 2010; 41: 506-12.